Introduction: PRP's Place in OA Management

Osteoarthritis affects over 32 million Americans, and knee OA alone accounts for more disability among older adults than any other condition. Traditional management—NSAIDs, physical therapy, corticosteroid injections, and eventual joint replacement—leaves many patients in a treatment gap. They're too symptomatic for conservative care alone but not ready for surgery.

Platelet-rich plasma (PRP) has emerged as a promising option to fill this gap. Unlike corticosteroids, which may accelerate cartilage degradation with repeated use, PRP works with the body's natural healing mechanisms. The clinical evidence has matured significantly over the past decade, and we now have a clearer picture of what PRP can—and cannot—accomplish.

This guide provides a practical framework for implementing PRP therapy in your practice, grounded in current evidence and real-world clinical experience.

Current State of OA Treatment Options

Before discussing PRP specifically, it's worth reviewing the treatment landscape:

Conservative Management

First-line approaches:

Weight management and activity modification
Physical therapy and exercise programs
Oral analgesics (acetaminophen, NSAIDs)
Topical treatments

Limitations: Many patients plateau despite optimal conservative care. NSAIDs carry cardiovascular, renal, and GI risks with long-term use.

Intra-articular Injections

Corticosteroids:

Rapid, short-term relief (weeks to months)
Repeated injections may accelerate cartilage loss
Typically limited to 3-4 injections per year

Hyaluronic Acid (Viscosupplementation):

Moderate evidence for symptom relief
Effects develop gradually, last several months
Generally well-tolerated

PRP:

Growing evidence base
May provide longer-lasting benefits than HA or corticosteroids
Potential disease-modifying effects (under investigation)

Surgical Options

Arthroscopy: Limited role in OA; may worsen outcomes in some cases

Osteotomy: Appropriate for select patients with malalignment

Joint Replacement: Definitive treatment but major surgery with recovery period

What is PRP and How Does It Work?

Basic Science

Platelet-rich plasma is an autologous blood product concentrated to contain higher platelet levels than whole blood. Typical whole blood contains 150,000-400,000 platelets/μL; quality PRP achieves 2-8x concentration.

Platelets contain over 1,500 bioactive proteins stored in alpha granules, including:

Growth Factors:

Platelet-derived growth factor (PDGF)
Transforming growth factor-beta (TGF-β)
Vascular endothelial growth factor (VEGF)
Insulin-like growth factor (IGF-1)
Epidermal growth factor (EGF)
Fibroblast growth factor (FGF)

Anti-inflammatory Mediators:

Hepatocyte growth factor
Interleukin-1 receptor antagonist

Mechanisms in Osteoarthritis

When injected into an osteoarthritic joint, PRP may:

Reduce inflammation - Growth factors modulate inflammatory cytokines
Stimulate cartilage repair - TGF-β and IGF-1 promote chondrocyte activity
Enhance synovial fluid properties - Improved viscosity and lubrication
Recruit repair cells - Chemotactic signals attract progenitor cells
Inhibit catabolic processes - Reduce matrix metalloproteinase activity

The exact mechanisms remain under investigation, but the clinical effects likely result from a combination of anti-inflammatory, anabolic, and microenvironment-modifying actions.

Review of Clinical Evidence

The evidence base for PRP in knee OA has grown substantially:

Meta-Analyses and Systematic Reviews

Key findings from recent high-quality reviews:

PRP shows statistically significant improvements in pain and function compared to placebo and hyaluronic acid
Benefits typically emerge at 2-3 months and may persist for 12+ months
Effect sizes are generally moderate (clinically meaningful for most patients)
Leukocyte-poor PRP may outperform leukocyte-rich formulations for OA

Notable Individual Studies

Filardo et al. (2021): Randomized trial of 192 patients showed PRP superior to HA at 12 months for pain and function.

Cole et al. (2017): Double-blind RCT demonstrated significant improvements with LP-PRP versus saline at 12 months.

Di Martino et al. (2019): Long-term follow-up showed sustained benefits at 24 months in responders.

Evidence Limitations

Important caveats when interpreting the literature:

Heterogeneity: Studies use different PRP preparations, concentrations, and protocols
Blinding challenges: True double-blinding is difficult with autologous products
Outcome measures: Various scales and timepoints complicate comparisons
Publication bias: Negative studies may be underreported

Current Consensus

Most orthopedic and sports medicine organizations recognize PRP as a reasonable option for knee OA when conservative measures have failed. It's not yet considered standard of care but has sufficient evidence to support clinical use.

Ideal Patient Candidates vs. Poor Candidates

Patient selection significantly impacts outcomes. Our clinical experience aligns with published predictors:

Ideal Candidates

Clinical characteristics:

Mild to moderate OA (Kellgren-Lawrence grades 1-3)
Age under 65 (though older patients can respond)
BMI under 30 (obesity reduces response rates)
Failed or plateaued with conservative care
Not ready for or declining joint replacement
Realistic expectations

Functional status:

Able to participate in post-injection activity modification
Motivated for rehabilitation protocols
Good overall health status

Poor Candidates

Relative contraindications:

Severe OA (K-L grade 4) with bone-on-bone changes
Significant mechanical derangement (meniscal tears, loose bodies)
Active infection (local or systemic)
Bleeding disorders or anticoagulation therapy
Unrealistic expectations of "cure"

Factors associated with reduced response:

Morbid obesity (BMI > 35)
Advanced age with multiple comorbidities
Significant inflammatory component (consider biologics instead)
Previous failed PRP (though different preparation may help)

Patient Selection Algorithm

We recommend a structured approach:

Confirm OA diagnosis - Clinical exam plus imaging
Grade severity - Kellgren-Lawrence classification
Assess prior treatments - Document conservative care attempts
Screen for contraindications - Labs if indicated
Set expectations - Honest discussion of anticipated outcomes
Obtain informed consent - Including off-label status in many jurisdictions

Injection Protocols and Frequency

Pre-Procedure Preparation

Medication management:

Hold NSAIDs for 5-7 days before procedure (controversial but commonly practiced)
Avoid corticosteroid injections for at least 4 weeks prior
Anticoagulants: individualize based on indication and bleeding risk

Patient instructions:

Hydrate well the day before and morning of procedure
Eat a normal meal (not fasting)
Avoid strenuous activity the day of procedure

PRP Preparation

System selection considerations:

FDA-cleared devices provide standardized preparation
Target platelet concentration: 4-6x baseline
Consider leukocyte-poor formulations for OA
Document system used and parameters achieved

Quality factors:

Consistent centrifugation protocol
Minimal red blood cell contamination
Appropriate volume for joint size (typically 4-8mL for knee)

Injection Technique

Approach options:

Superolateral (most common)
Superomedial
Anterolateral (infrapatellar)
Ultrasound-guided (improves accuracy)

Procedural notes:

Strict sterile technique
Consider local anesthetic to skin only (avoid intra-articular lidocaine which may affect platelet function)
Aspirate effusion if present before injecting PRP
Slow injection to minimize discomfort

Post-Injection Protocol

Immediate (first 48-72 hours):

Relative rest (avoid strenuous activity)
Ice as needed for discomfort
Acetaminophen for pain (avoid NSAIDs)
Expect mild-moderate soreness

Short-term (weeks 1-4):

Gradual return to activity
Physical therapy can begin at 1-2 weeks
Avoid impact activities initially

Series protocol:

Single injection: reasonable first-line approach
Series of 3 injections (weekly or biweekly): may improve response rates
Decision based on patient response and preferences

Documentation for Medical Necessity

Proper documentation supports appropriate use and may facilitate coverage:

Required Elements

History:

Duration and progression of symptoms
Impact on function and quality of life
Prior treatments attempted and responses
Contraindications to alternatives (e.g., NSAID intolerance)

Physical Examination:

Joint-specific findings
Range of motion measurements
Functional assessment

Imaging:

Radiographs documenting OA severity
MRI if indicated for additional pathology

Medical Necessity Statement:

Conservative care failure
Rationale for PRP selection
Expected goals of treatment

Coding Considerations

PRP coding remains complex and varies by payer:

CPT codes for injection and preparation
Document time spent on preparation if billing separately
Check individual payer policies
Consider cash-pay options where coverage is denied

Setting Patient Expectations

Honest communication prevents dissatisfaction:

What to Tell Patients

Realistic benefits:

Most patients experience meaningful improvement
Pain reduction typically 30-50% in responders
Effects develop over 4-8 weeks
Benefits may last 6-12+ months
Not everyone responds

Limitations:

PRP cannot regenerate severely damaged cartilage
It's not a cure for osteoarthritis
May need repeat treatments
Still need to manage weight, activity, overall health
Progression may continue despite treatment

Process expectations:

Initial soreness is normal (24-72 hours)
Improvement is gradual, not immediate
Full effect assessment at 6-8 weeks
May recommend additional injections based on response

Common Pitfalls and How to Avoid Them

Clinical Pitfalls

Treating inappropriate candidates:

Solution: Strict selection criteria, imaging review, honest assessment

Inadequate PRP quality:

Solution: Use validated FDA-cleared systems, verify concentrations

Poor injection technique:

Solution: Consider ultrasound guidance, ongoing training

Unrealistic promises:

Solution: Honest informed consent, written expectations

Business Pitfalls

Underpricing services:

Solution: Calculate true costs including supplies, time, overhead

No follow-up protocol:

Solution: Systematic outcome tracking, scheduled reassessments

Inadequate documentation:

Solution: Templated notes, compliance review

Conclusion

PRP therapy for knee osteoarthritis represents a scientifically grounded option for patients in the treatment gap between conservative care and surgery. The evidence supports its use as a safe intervention with moderate efficacy for appropriately selected patients.

Success depends on:

Careful patient selection
Quality PRP preparation with validated systems
Proper technique and post-procedure protocols
Realistic expectation setting
Systematic outcome tracking

At Hawk Medical, we help practices implement PRP programs with FDA-cleared systems and comprehensive support. Our experience as clinical practice owners means we understand the practical challenges you'll face.

Interested in adding PRP therapy to your practice? Contact us to learn about FDA-cleared PRP preparation systems and implementation support.

Introduction: PRP's Place in OA Management

This guide provides a practical framework for implementing PRP therapy in your practice, grounded in current evidence and real-world clinical experience.